Nope. The way I see it is the patients have 2 possible outcomes:
* Poor mortality rate, with limited survival.
or with MSB
* Unproven, confounded data, still poor survival rate, parents impoverished by using Ryoncil in a last gasp effort thanks toDisallowed salesmenMSB
The only difference between shonky stem cell practices profiteering off dodgy claims and MSB is a fancy logo and plush offices in NY and MLB.
Ann: Update on BLA for Graft Versus Host Disease, page-438
-
- There are more pages in this discussion • 580 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.015(1.28%) |
Mkt cap ! $1.353B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $4.111M | 3.470M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 27511 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 77376 | 8 |
View Market Depth
| Last trade - 15.01pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |